CLINICAL_TRIALS trial_result · 2024-03-26

Clinical Trial Update: TXA in Anticoagulated Patients Study [Phase 4]

Phase 4 trial update for TXA in anticoagulated patients undergoing total shoulder arthroplasty has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: NYU Langone Health | Conditions: Total Shoulder Athroplasty | Phase 4 | Status: TERMINATED | Results posted: 2024-03-26